Cushing's Syndrome and Topical Corticosteroids in Pediatrics: A Systematic Review Berun A. Abdalla, Honar O. Kareem, Bilal A. Mohammed, Karzan M. Hasan, Soran M. Ahmed, Khdir Hussein Hamad Khoshnaw, Wirya N. Sabr, Ronak S. Ahmed and 6 more Introduction Despite the increasing number of pediatric cases of iatrogenic Cushing's syndrome (CS) due to topical corticosteroids, systematic reviews are lacking to provide comprehensive insights into the disease. This study aims to provide a systematic overview of the disease. Methods Relevant literature was… 2024 1,553 reads 2 citations doi:10.58742/bmj.v2i3.104 Full text PDF XML Read abstract — read the abstract for Cushing's Syndrome and Topical Corticosteroids in Pediatrics: A Systematic Review Review Articles Cushing's Syndrome and Topical Corticosteroids in Pediatrics: A Systematic Review Berun A. Abdalla, Honar O. Kareem, Bilal A. Mohammed, Karzan M. Hasan, Soran M. Ahmed, Khdir Hussein Hamad Khoshnaw, Wirya N. Sabr, Ronak S. Ahmed and 6 more IntroductionDespite the increasing number of pediatric cases of iatrogenic Cushing's syndrome (CS) due to topical corticosteroids, systematic reviews are lacking to provide comprehensive insights into the disease. This study aims to provide a systematic overview of the disease. MethodsRelevant literature was identified using Google Scholar and PubMed. The search strategy was restricted to studies on human published in English. The inclusion criteria encompassed confirmed pediatric cases of iatrogenic CS induced by topical corticosteroids. ResultsThe mean age of the cases was 38.8 months, with a female gender predominance (57.1%). Abnormalities in growth patterns were observed in approximately 75% of the cases. The most common clinical presentation was a "moon face" appearance (74.6%), followed by weight gain (55.5%). Clobetasol propionate was the most frequently used topical steroid (54%), followed by betamethasone types (35%). The mean duration of steroid use was 25.4 weeks. The primary indications for steroid use were dermatitis (47.6%), psoriasis (17.5%), and scabies (15.9%). Laboratory tests for adrenocorticotropic hormone and cortisol levels revealed low levels in 73% and 78% of cases, respectively. All cases had their initial steroid discontinued. Oral hydrocortisone was the primary replacement therapy (39.7%), followed by sulfur cream (12.7%). Fifty-one cases (81%) recovered from the disease. Partial recovery was observed in 2 cases (3.2%), while four cases (6.3%) did not survive. ConclusionA specialist should supervise topical corticosteroid administration, and parents need to be fully informed about the proper usage and potential side effects to avoid iatrogenic CS and other complications. Keywords Cushing syndrome · Cushingoid · Steroids · Hormonal imbalance · Cortisol · ACTH All subjects Barw Medical Journal. 2024;2(4) Read the article PDF XML
